ストックスクリーナーアプリを入手
0.8206
1.94%
0.0124
前日終値:
$0.8082
開ける：
$0.83
24時間の取引高:
1.08M
Relative Volume:
1.65
時価総額：
$5.16M
収益：
$5.66M
当期純損益:
$-15.88M
株価収益率:
-0.0725
EPS:
-11.3134
ネットキャッシュフロー:
$-10.93M
1週間 パフォーマンス:
+1.46%
1か月 パフォーマンス:
-52.38%
6か月 パフォーマンス:
-36.14%
1年 パフォーマンス:
-90.63%
1日の値動き範囲:
$0.81
$0.836
1週間の範囲:
$0.7823
$0.87
52週間の値動き範囲:
$0.693
$13.50
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
名前
Bioaffinity Technologies Inc
セクター
電話
210-698-5334
住所
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, NTRA, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.8207 | 5.10M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
519.22 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
194.74 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
572.36 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
281.77 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
377.49 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Bioaffinity Technologies Inc (BIAF) 最新ニュース
bioAffinity Technologies Sees Record CyPath® Lung Test Sales, Expands Veteran Screening with Philips Partnership - Minichart
bioAffinity Technologies reports accelerated CyPath Lung sales, Philips partnership to boost veteran screening - TradingView
CyPath Lung sales surge as bioAffinity (NASDAQ: BIAF) expands pipeline - Stock Titan
bioAffinity Technologies Company Profile & Introduction - Moomoo
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - Stocktwits
bioAffinity Technologies Inc (BIAF) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells - BioSpace
bioAffinity Technologies reports skin cancer siRNA preclinical results - grafa.com
bioAffinity to present skin cancer treatment research - Investing.com
bioAffinity to present skin cancer treatment research By Investing.com - Investing.com South Africa
BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart - ChartMill
BioAffinity Technologies Closes $3.2 Million Public Offering - Moomoo
bioAffinity Technologies Raises $3.2M in Best-Efforts Offering, Signs Purchase and Placement Pacts - TradingView
bioAffinity Technologies Inc (BIAFW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies (NASDAQ: BIAF) raises $3.2M in stock and pre-funded warrant sale - Stock Titan
bioAffinity Technologies Announces Closing of $3.2 Million Offering - Quantisnow
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies closes $3.2M public offering By Investing.com - Investing.com Nigeria
bioAffinity Technologies closes $3.2M public offering - Investing.com
BIOAFFINITY TECHNOLOGIES ANNOUNCES CLOSING OF $3.2 MILLION OFFERING - Moomoo
bioAffinity Technologies Inc (BIAFW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies Inc (BIAFW) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAFW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAFW) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity (NASDAQ: BIAF) to sell 1.04M shares, up to 2.96M pre-funded warrants - Stock Titan
bioAffinity Technologies Inc (BIAF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
bioAffinity Technologies Inc (BIAF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13% - Moomoo
bioAffinity Technologies (BIAF) Slides Nearly 12% – Testing Key Support at $0.79Impulse Wave - newsline.com
bioAffinity Technologies Inc (BIAF) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies Inc (BIAF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAF) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies prices $3.2M public offering By Investing.com - Investing.com India
bioAffinity Technologies prices $3.2M public offering - Investing.com UK
WallachBeth Capital Announces Pricing of bioAffinity Technologie - GuruFocus
bioAffinity Technologies closes $3.2 million public offering - scanx.trade
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies Announces Pricing of $3.2 Million Offering - Business Wire
bioAffinity Technologies Inc (BIAFW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAFW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAFW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
[EFFECT] bioAffinity Technologies, Inc. SEC Filing - Stock Titan
bioAffinity (BIAF) S-1/A adds placement agency pact and warrant forms - Stock Titan
bioAffinity to participate in veterans lung health webinar By Investing.com - Investing.com Australia
bioAffinity to participate in veterans lung health webinar - Investing.com
bioAffinity Technologies to host July 21 webinar on veteran lung screening with Philips and 4DMedical - TradingView
Veteran lung health webinar from bioAffinity (BIAF) spotlights CyPath® Lung - Stock Titan
Bioaffinity Technologies Inc (BIAF) 財務データ
収益
当期純利益
現金流量
EPS
1.74%
0.08%
大文字化:
|
ボリューム (24 時間):